What happened
Shares of Laboratory Corp. of America (NYSE: LH), also known as Labcorp, were down more than 13% as of 12:15 p.m. ET on Monday after the company announced it had completed its spinoff of Fortrea Holdings (NASDAQ: FTRE), a contract research organization. The stock is up more than 2% this year.
So what
Labcorp is a healthcare diagnostics and laboratory services company, with more than 60,000 employees and clients in more than 100 countries. The company said more than 80% of the new drugs the Food and Drug Administration (FDA) approved last year were worked on by Labcorp.
The move downward was just a simple case of investors selling on the news, as the anticipation of which had already helped raise the stock's price more than 11% over the past month. The deal is generally positive for Labcorp, as Fortrea was paying Labcorp roughly $1.6 billion for assets connected with the deal. Labcorp said it was using the money to pay down debt and toward a $1 billion share repurchase program. Fortrea began trading on the Nasdaq on Monday, and each Labcorp investor was given a share of Fortrea for every share of Labcorp they owned.
Now what
Labcorp is coming off a lackluster first-quarter report. It said it had quarterly revenue of $3.78 billion, down 40% year over year, and earnings per share (EPS) of $2.39, compared to $5.23 in the same period last year.
The culprit is that the company's COVID-19 testing was down, so that trend will likely continue. Labcorp downgraded guidance to say it expected 2023 adjusted EPS of $16.25, down from earlier estimates of $17.75.
10 stocks we like better than Laboratory Corporation of America
When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Laboratory Corporation of America wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of July 3, 2023
Jim Halley has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
